Oclacitinib Impurity 25 CAS 1480743-81-4

Purity ≥95%In StockPharmacopoeial Impurity Standards
CAS No.1480743-81-4
Molecular FormulaC15H27NO4
Molecular Weight285.38 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Oclacitinib Impurity 25 CAS 1480743-81-4 chemical structure

Description

Structurally, Oclacitinib Impurity 25 (C15H27NO4) contains an amide group, a carboxylic acid group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 3.0, corresponding to approximately 3 ring(s) or double-bond equivalent(s). With a molecular weight of 285.38 g/mol, it falls into the medium-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

Oclacitinib Impurity 25 (CAS 1480743-81-4) is a certified pharmaceutical impurity reference standard with the molecular formula C15H27NO4 and a molecular weight of 285.38 g/mol.

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Molecular FormulaC15H27NO4
Molecular Weight285.38 g/mol
AppearanceWhite to pale yellow crystalline powder
Purity≥95%
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)3.0
UV AbsorptionUV-absorbing
CAS Registry Year (est.)1992
Nitrogen Atoms1

Related Oclacitinib Standards

Recommended Standards

Why CATO?